115 related articles for article (PubMed ID: 38293814)
1. Tumor markers for lipid metabolism-related genes: Based on small cell lung cancer and bronchial asthma dual analysis.
Wang X; Gao Y; Wang H; Gong X; Bao P
Environ Toxicol; 2024 May; 39(5):2855-2868. PubMed ID: 38293814
[TBL] [Abstract][Full Text] [Related]
2. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
[TBL] [Abstract][Full Text] [Related]
3. Identification of potential diagnostic biomarkers for tenosynovial giant cell tumour by integrating microarray and single-cell RNA sequencing data.
Chen C; Zheng L; Zeng G; Chen Y; Liu W; Song W
J Orthop Surg Res; 2023 Nov; 18(1):905. PubMed ID: 38017559
[TBL] [Abstract][Full Text] [Related]
4. A novel signature incorporating lipid metabolism- and immune-related genes to predict the prognosis and immune landscape in hepatocellular carcinoma.
Yang T; Luo Y; Liu J; Liu F; Ma Z; Liu G; Li H; Wen J; Chen C; Zeng X
Front Oncol; 2023; 13():1182434. PubMed ID: 37346073
[TBL] [Abstract][Full Text] [Related]
5. Integration of Single-Cell RNA Sequencing and Bulk RNA Sequencing Data to Establish and Validate a Prognostic Model for Patients With Lung Adenocarcinoma.
Jiang A; Wang J; Liu N; Zheng X; Li Y; Ma Y; Zheng H; Chen X; Fan C; Zhang R; Fu X; Yao Y
Front Genet; 2022; 13():833797. PubMed ID: 35154287
[No Abstract] [Full Text] [Related]
6. Integrating RNA-seq and scRNA-seq to explore the biological significance of NAD + metabolism-related genes in the initial diagnosis and relapse of childhood B-cell acute lymphoblastic leukemia.
Lin C; Xu JQ; Zhong GC; Chen H; Xue HM; Yang M; Chen C
Front Immunol; 2022; 13():1043111. PubMed ID: 36439178
[TBL] [Abstract][Full Text] [Related]
7. Integration of scRNA-Seq and Bulk RNA-Seq to Analyse the Heterogeneity of Ovarian Cancer Immune Cells and Establish a Molecular Risk Model.
Liang L; Yu J; Li J; Li N; Liu J; Xiu L; Zeng J; Wang T; Wu L
Front Oncol; 2021; 11():711020. PubMed ID: 34621670
[TBL] [Abstract][Full Text] [Related]
8. Identification of Five Hub Genes Based on Single-Cell RNA Sequencing Data and Network Pharmacology in Patients With Acute Myocardial Infarction.
Song Z; Gao P; Zhong X; Li M; Wang M; Song X
Front Public Health; 2022; 10():894129. PubMed ID: 35757636
[TBL] [Abstract][Full Text] [Related]
9. Construction of Prognostic Risk Model for Small Cell Lung Cancer Based on Immune-Related Genes.
Deng F; Tao F; Xu Z; Zhou J; Gong X; Zhang R
Comput Math Methods Med; 2022; 2022():7116080. PubMed ID: 36245844
[TBL] [Abstract][Full Text] [Related]
10. Identification of candidate biomarkers and pathways associated with SCLC by bioinformatics analysis.
Wen P; Chidanguro T; Shi Z; Gu H; Wang N; Wang T; Li Y; Gao J
Mol Med Rep; 2018 Aug; 18(2):1538-1550. PubMed ID: 29845250
[TBL] [Abstract][Full Text] [Related]
11. Exploring biomarkers and transcriptional factors in type 2 diabetes by comprehensive bioinformatics analysis on RNA-Seq and scRNA-Seq data.
Huang Y; Cai L; Liu X; Wu Y; Xiang Q; Yu R
Ann Transl Med; 2022 Sep; 10(18):1017. PubMed ID: 36267740
[TBL] [Abstract][Full Text] [Related]
12. Identification of Six Novel Prognostic Gene Signatures as Potential Biomarkers in Small Cell Lung Cancer.
Feng S; Zhang X; Gu X; Zhou M; Chen Y; Wang C
Comb Chem High Throughput Screen; 2023; 26(5):938-949. PubMed ID: 35490316
[TBL] [Abstract][Full Text] [Related]
13. The identification of hub biomarkers and pathways in lung cancer and prognostic evaluation.
Yin Y; Li D; He M; Wang J
Transl Cancer Res; 2022 Aug; 11(8):2622-2635. PubMed ID: 36093542
[TBL] [Abstract][Full Text] [Related]
14. Construction of an immune-related gene signature for the prognosis and diagnosis of glioblastoma multiforme.
Yu Z; Yang H; Song K; Fu P; Shen J; Xu M; Xu H
Front Oncol; 2022; 12():938679. PubMed ID: 35982954
[TBL] [Abstract][Full Text] [Related]
15. Identification of candidate genes associated with the pathogenesis of small cell lung cancer via integrated bioinformatics analysis.
Liao Y; Yin G; Wang X; Zhong P; Fan X; Huang C
Oncol Lett; 2019 Oct; 18(4):3723-3733. PubMed ID: 31516585
[TBL] [Abstract][Full Text] [Related]
16. Integrative Analysis of Single-Cell and Bulk RNA Sequencing Reveals Prognostic Characteristics of Macrophage Polarization-Related Genes in Lung Adenocarcinoma.
Mi K; Zeng L; Chen Y; Yang S
Int J Gen Med; 2023; 16():5031-5050. PubMed ID: 37942473
[TBL] [Abstract][Full Text] [Related]
17. A Novel Hypoxia-Related Gene Signature with Strong Predicting Ability in Non-Small-Cell Lung Cancer Identified by Comprehensive Profiling.
Yang H; Wang Z; Gong L; Huang G; Chen D; Li X; Du F; Lin J; Yang X
Int J Genomics; 2022; 2022():8594658. PubMed ID: 35634481
[TBL] [Abstract][Full Text] [Related]
18. Bioinformatics analysis of mRNA and miRNA microarray to identify the key miRNA‑gene pairs in small‑cell lung cancer.
Mao Y; Xue P; Li L; Xu P; Cai Y; Chu X; Jiang P; Zhu S
Mol Med Rep; 2019 Sep; 20(3):2199-2208. PubMed ID: 31257520
[TBL] [Abstract][Full Text] [Related]
19. Integrative analysis reveals a four-gene signature for predicting survival and immunotherapy response in colon cancer patients using bulk and single-cell RNA-seq data.
Chai R; Zhao Y; Su Z; Liang W
Front Oncol; 2023; 13():1277084. PubMed ID: 38023180
[TBL] [Abstract][Full Text] [Related]
20. Identification of key monocytes/macrophages related gene set of the early-stage abdominal aortic aneurysm by integrated bioinformatics analysis and experimental validation.
Cheng S; Liu Y; Jing Y; Jiang B; Wang D; Chu X; Jia L; Xin S
Front Cardiovasc Med; 2022; 9():950961. PubMed ID: 36186997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
